Health

Idaho officials on Monday asked the U.S. Supreme Court to temporarily halt a federal judge’s ruling that blocked the Republican-run state from enforcing a near-total

Novartis raised its sales growth target to 5% a year to 2027, citing demand for innovative medicines following the spin-off of its generics business. The

US vaccine maker Moderna began constructing its first plant in China to produce mRNA-based drugs this month, the company said on Tuesday.

GSK said on Monday that its blood cancer drug Blenrep has hit a key late-stage trial target, potentially boosting the British drugmaker’s oncology division after

Japan has detected the season’s first highly pathogenic H5-type bird flu at a poultry farm in the south of the country, public broadcaster NHK reported

French drugmaker Valneva said Monday that an application for its candidate vaccine against the mosquito-borne viral disease chikungunya has been accepted by the European Medicines

Zimbabwe’s government has begun restricting public gatherings and the sale of food after a spike in cholera cases. New cholera cases in the southern African

Novo Nordisk will launch its popular anti-obesity drug Wegovy in Japan on 22 February, its first launch in Asia. The Danish company has chosen Japan

Leading scientists urged caution amid fears of another pandemic after the World Health Organisation requested more information from China on a rise in respiratory illnesses

Danish drugmaker Novo Nordisk said on Thursday it will invest more than 16 billion crowns ($2.34 billion) to expand its manufacturing capacity at Chartres in